Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Capital Expenditures: 2019-2024

Historic Capital Expenditures for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to $1.2 million.

  • MDxHealth's Capital Expenditures fell 25.24% to -$263,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.6 million, marking a year-over-year increase of 39.92%. This contributed to the annual value of $1.2 million for FY2024, which is 56.75% down from last year.
  • Per MDxHealth's latest filing, its Capital Expenditures stood at $1.2 million for FY2024, which was down 56.75% from $2.7 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Capital Expenditures ranged from a high of $2.8 million in FY2022 and a low of $537,000 during FY2020.
  • Over the past 3 years, MDxHealth's median Capital Expenditures value was $2.7 million (recorded in 2023), while the average stood at $2.2 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 635.62% in 2020, then tumbled by 56.75% in 2024.
  • Over the past 5 years, MDxHealth's Capital Expenditures (MRY) stood at $537,000 in 2020, then skyrocketed by 66.85% to $896,000 in 2021, then surged by 211.27% to $2.8 million in 2022, then fell by 1.51% to $2.7 million in 2023, then plummeted by 56.75% to $1.2 million in 2024.
  • Its Capital Expenditures stands at $1.2 million for FY2024, versus $2.7 million for FY2023 and $2.8 million for FY2022.